SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

158 hedge funds and large institutions have $742M invested in Sangamo Therapeutics in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
4.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
51
Reduced
47
Closed
21
Calls
$196M
Puts
$8.47M
Net Calls
+$188M
Net Calls Change
+$55.4M

Top Buyers

1
Bank of New York Mellon
1
Bank of New York Mellon
New York
$23.8M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$11.3M
3
VOYA Investment Management
3
VOYA Investment Management
Georgia
$9M
4
Allianz Asset Management
4
Allianz Asset Management
Germany
$10.6M
5
EAM
5
EverPoint Asset Management
Connecticut
$16.7M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$62.4M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$2.4M
3
NI
3
Numeric Investors
Massachusetts
$578K
4
FCM
4
Frontier Capital Management
Massachusetts
$28.3M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$35M
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
176
Tower Research Capital (TRC)
New York
– -$5K -425 Closed
Ameriprise
177
Ameriprise
Minnesota
– -$5K -420 Closed
OCM
178
One Capital Management
California
– -$1K -100 Closed
4 5 6 7
8